New trial opening for Relapsing Osteosarcoma patients

Little has changed in our medical treatment for the most common Bone Sarcoma in children, Osteosarcoma, over the past 30+ years.  Several phase I trials and translational studies show promise for those patients battling relapsed or progressive disease.  A phase II COG trial is about to open for relapsing patients using Denosumab in combination with other agents.  Details of the study can

Subscribe To Our Newsletter

Enter your email below to join our mailing list.